NEW YORK – Software and reagent technology firm ChromaCode announced Wednesday its HDPCR SARS-CoV-2 Real-Time PCR assay received Emergency Use Authorization from the US Food and Drug Administration.
The test detects the virus from nasopharyngeal swab specimens and runs on standard qPCR instruments, including Thermo Fisher Scientific's Applied Biosystems 7500 Fast machine. Labs can run more than 1,000 samples per qPCR instrument in 24 hours, the firm said.